Evidence mapPaperPMID 39076964Full record

ReviewReviews in cardiovascular medicine2024

Hypertensive Heart Disease: Mechanisms, Diagnosis and Treatment.

Xuewei Huang, Lizhi Hu, Zhuojun Long, Xinyao Wang, Junru Wu, Jingjing Cai

Abstract readReview
In one paragraph

Review in Reviews in cardiovascular medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. NF-Frontiers in cardiovascular medicine · 2026
    Article
  2. Review
  3. Article
  4. Multitarget mechanisms of the herb pairFrontiers in pharmacology · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xuewei HuangDepartment of Cardiology, The Third Xiangya Hospital, Central South University, 410013 Changsha, Hunan, China.
Lizhi HuXiangya School of Medicine, Central South University, 410013 Changsha, Hunan, China.
Zhuojun LongXiangya School of Medicine, Central South University, 410013 Changsha, Hunan, China.
Xinyao WangXiangya School of Medicine, Central South University, 410013 Changsha, Hunan, China.
Junru WuDepartment of Cardiology, The Third Xiangya Hospital, Central South University, 410013 Changsha, Hunan, China.
Jingjing CaiDepartment of Cardiology, The Third Xiangya Hospital, Central South University, 410013 Changsha, Hunan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertensive heart disease (HHD) presents a substantial global health burden, spanning a spectrum from subtle cardiac functional alterations to overt heart failure. In this comprehensive review, we delved into the intricate pathophysiological mechanisms governing the onset and progression of HHD. We emphasized the significant role of neurohormonal activation, inflammation, and metabolic remodeling in HHD pathogenesis, offering insights into promising therapeutic avenues. Additionally, this review provided an overview of contemporary imaging diagnostic tools for precise HHD severity assessment. We discussed in detail the current potential treatments for HHD, including pharmacologic, lifestyle, and intervention devices. This review aimed to underscore the global importance of HHD and foster a deeper understanding of its pathophysiology, ultimately contributing to improved public health outcomes.

Indexed as

diagnosishypertensive heart diseasemechanismstreatment

Identifiers

PMID39076964
PMCPMC11263885

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.